Cannabinoid receptor ligands

Details Cannabinoid receptor ligands Cannabinoid receptor ligands

2006-07-04

2006-07-04

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S201000

Reexamination Certificate

active

07071213

ABSTRACT:
There are disclosed compounds of the formula I:or a pharmaceutically acceptable salt of the compound, which exhibit anti-inflammatory and immunomodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds.

REFERENCES:
patent: 4466965 (1984-08-01), Stout et al.
patent: 4567184 (1986-01-01), Musser et al.
patent: 5332820 (1994-07-01), Duncia et al.
patent: 5338753 (1994-08-01), Burstein et al.
patent: 5462960 (1995-10-01), Barth et al.
patent: 5486525 (1996-01-01), Summers, Jr. et al.
patent: 5532237 (1996-07-01), Gallant et al.
patent: 5866589 (1999-02-01), Romero et al.
patent: 5925768 (1999-07-01), Barth et al.
patent: 5948777 (1999-09-01), Bender et al.
patent: 5990170 (1999-11-01), Della Valle et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: 6017919 (2000-01-01), Inaba et al.
patent: 19533644 (1995-09-01), None
patent: 0181568 (1986-05-01), None
patent: 0401030 (1990-12-01), None
patent: 0407217 (1991-01-01), None
patent: 1031571 (2000-08-01), None
patent: 1283039 (2003-02-01), None
patent: 1314733 (2003-05-01), None
patent: 06072979 (1994-03-01), None
patent: WO 93/21158 (1993-10-01), None
patent: WO 96/23783 (1996-08-01), None
patent: WO 97/03953 (1997-02-01), None
patent: WO 98/10763 (1998-03-01), None
patent: WO 98/31227 (1998-07-01), None
patent: WO 98/33769 (1998-08-01), None
patent: WO 98/41519 (1998-09-01), None
patent: WO 99/26612 (1999-06-01), None
patent: WO 99/36393 (1999-07-01), None
patent: WO 99/50245 (1999-10-01), None
patent: WO 00/06146 (2000-02-01), None
patent: WO 01/37826 (2001-05-01), None
patent: WO 01/44172 (2001-06-01), None
patent: WO 01/44239 (2001-06-01), None
patent: WO 01/64642 (2001-09-01), None
patent: WO 01/70753 (2001-09-01), None
patent: WO 01/74762 (2001-10-01), None
patent: WO 01/83460 (2001-11-01), None
patent: WO 02/062750 (2002-08-01), None
patent: WO 03/042174 (2003-05-01), None
Swain et al. “Dihydroergot analogs . . . ” CA 52:21120 (1958).
Howlett et al. “Cannabioid receptor agonists . . . ” CA 124:219022 (1996).
Sacerdote et al. “In vivo and in vitro treatment with . . . ” CA 134:13272 (2000).
Sasaki et al. “Nitrogen containing aromatic . . . ” CA 135:14337 (2001).
Sato et al. “Preparation of sulfonylaminomethyl . . . ” CA 135:61247 (2001).
Lutz “Molecular biology of cannabionoid receptors” CA 138:526698 (2002).
Boss et al. “Preparation of substituted . . . ” CA 140:77034 (2004).
Romero et al. “Antiaids heteroaryl . . . ” CA 125:142777 (1996).
Shiota et al. “Preparation of cyclic amine . . . ” CA 134:5154 (2000).
Nazare et al. “Preparation of indole . . . ” CA 139:6766 (2000).
Hickey et al. “Preparation of novel amino . . . ” CA 138:24952 (2002).
M. Curtin et al., “Discovery and Evaluation of a Series of 3-Acylindole Imidazopyridine Platelet-Activating Factor Antagonists”, 41(1)J. Med. Chem. 74-95 (1998).
G. Hartman et al., “4-Substituted Thiophene—and Furan—2-sulfonamides as topical carbonic anhydrase Inhibitors” 35(21)J. Med. Chem. 3822-31 (1992).
G. Hartman et al., “Synthesis and derivatization of 4-(arylsulfonyl) thiophene- and—furan-2 sulfonamides”, 27(2)J. Heterocycl. Chem. 127-34 (1990).
P. Cozzi et al., New N-(2-ethoxyethyl)-N-(4-phenoxybenzyl) dichloroacetamides as potent antiamoebic agents 18(3)Eur. J. Med. Chem. 203-208 (1983).
U.S. Appl. No. 03/024,398 (AL01381K1) for “Cannabinoid Receptor Ligands”, filed Aug. 5, 2003.
U.S. Appl. No. 10/464,174 (AL01561K) for “Cannabinoid Receptor Agonists”, filed Jun. 17, 2003.
R.G. Pertwee, “Pharmacology of Cannabinoid Receptor Ligands”, Curr. Med. Chem 6(8), (1999), 635-664.
T.W. Greene et al. Protective Groups in Organic Synthesis (1981), Wiley, New York.
T. Higuchi and V. Stella, Pro-drugs as Novel Drug Delivery Systems (1975) 14 of the A.C.S. Symposium Series.
Bio reversible Carriers in Drug Design, (1987) Edward B. Roche, ed., American Pharmaceutical Association and Pergamon Press.
S. Berge et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences (1977) 66(1) 1-19.
P. Gould, “Salt Selection for Basic Drugs”, International J. of Pharmaceutics (1986) 33 201-217.
Anderson et al, The Practice of Medicinal Chemistry (1996), Academic Press, New York.

Affiliated with

Also associated with

Rating

Cannabinoid receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cannabinoid receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannabinoid receptor ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3563992